Login / Signup
Holly Flores
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Systematic Review
Meta Analyses
Botulinum Toxin
Top Venues
Clinical drug investigation
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Katherine Cox
,
Merhawit Ghebrehiwet
,
Micah Kee
,
Brayden M Rucker
,
Holly Flores
,
Ryan Ottwell
,
Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin.
Clinical drug investigation
(2023)
Katherine Cox
,
Merhawit Ghebrehiwet
,
Micah Kee
,
Brayden M Rucker
,
Holly Flores
,
Ryan Ottwell
,
Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin.
Clinical drug investigation
43 (2) (2023)
Katherine Cox
,
Merhawit Ghebrehiwet
,
Micah Kee
,
Brayden M Rucker
,
Holly Flores
,
Ryan Ottwell
,
Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin.
Clinical drug investigation
43 (2) (2023)
Katherine Cox
,
Merhawit Ghebrehiwet
,
Micah Kee
,
Brayden M Rucker
,
Holly Flores
,
Ryan Ottwell
,
Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin.
Clinical drug investigation
43 (2) (2023)
Katherine Cox
,
Merhawit Ghebrehiwet
,
Micah Kee
,
Brayden M Rucker
,
Holly Flores
,
Ryan Ottwell
,
Matt Vassar
Assessing the Reporting of Harms in Systematic Reviews Focused on the Therapeutic and Cosmetic Uses of Botulinum Toxin.
Clinical drug investigation
43 (2) (2023)